Sinco Pharmaceuticals Holdings Limited

HKEX:6833.HK

0.184 (HKD) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q4
Operating Activities:
Net Income 23.8722.75719.5957.53961.92359.80275.28185.68532.4528.34515.207-231.878-48.736-154.376-31.52-11.69531.06220.91548.69935.17134.19617.342
Depreciation & Amortization 10.1119.0167.3036.4464.913.3933.2844.1695.2275.1515.1825.0995.2647.7267.5235.3685.235.1925.0371.2090.6690.47
Deferred Income Tax 000000000212.032-161.694100.786-69.652110.75283.938-98.242000000
Stock Based Compensation 0000000000.137-0.050.2720.2680.6480.7040.995000000
Change In Working Capital 0-282.327117.96989.24-121.42254.545363.472-384.673-9.053-323.648147.13564.73106.308-223.014-47.04883.581-85.8327.539-119.71333.544-81.15-9.129
Accounts Receivables 0-240.40844.518-108.739-25.13383.064281.002-483.369-64.25833.169-39.02856.938-47.12412.224-29.462169.168-100.099-40.27021.036-21.0360
Change In Inventory 0-98.5578.672-42.90216.02438.773142.51822.992-9.535-245.338200.772-157.996116.508-123.624-55.18-71.92124.05747.466.65342.2716.13812.102
Change In Accounts Payables 000000000000000000025.53321.2310
Other Working Capital 056.631-5.221240.881-112.313-67.292-60.04875.70464.74-111.479-14.609165.78836.924-111.61437.594-13.666-9.78820.349-126.366-29.763-66.252-21.231
Other Non Cash Items -301.981178.469280.918-115.858142.303106.299-360.364520.844-117.351181.364-48.371324.01830.54798.519-17.816-116.81858.204-45.204103.73120.3519.1474.602
Operating Cash Flow -268-72.085425.785-12.63387.714224.03981.673226.025-88.725-128.651119.103162.24193.651-270.497-88.157-38.5698.6668.44237.75490.275-37.13813.284
Investing Activities:
Investments In Property Plant And Equipment -15.586-12.986-16.564-30.027-22.664-21.369-2.153-0.363-0.009-0.454-0.101-0.484-0.67-1.571-2.854-10.429-1.608-3.534-6.711-13.513-19.934-8.362
Acquisitions Net 0000-6800000000-3.096-3.52-50.188-9.5-3-19000
Purchases Of Investments 0000000000000000000-3.500
Sales Maturities Of Investments 0000000000000000000000
Other Investing Activites -5.891-3.013-31.0630.8040.6170.2770.518-48.8262.356-1.904-0.086-0.258-0.218116.044-33.018-110.335-24.146-21.385-0.034-9.6241.4438.362
Investing Cash Flow -21.477-15.999-47.627-29.223-90.047-21.092-1.635-49.1892.347-2.358-0.187-0.742-0.888111.377-39.392-170.952-35.254-27.919-25.745-23.137-18.491-10.417
Financing Activities:
Debt Repayment 00-18.7520-117.6880-120.9570-94.7210-0.4650-30.5590-34.6840000-68.448-94.38-94.38
Common Stock Issued 0000000000000000000000
Common Stock Repurchased 000-6.067000000000000000000
Dividends Paid 00-18.112000000000000-4.64800000-1.25
Other Financing Activities 115.625-1.236-189.133-83.5156.937-141.933-76.132-117.65142.497324.247-167.339-161.314-118.844102.30872.506-0.445327.0143.198-6.266-66.20380.50495.63
Financing Cash Flow 115.625-1.236-188.493-89.582124.625-141.93344.825-117.651-52.224324.247-167.804-161.314-88.285102.308107.19-5.093327.0143.198-6.266-66.20380.504-98.423
Other Information:
Effect Of Forex Changes On Cash 17.9396.422.0133.8758.363-1.964-1.626-1.424-0.150.0150.0480.402-0.373-0.528-0.7294.453.6110.3710.155-0.0490.7860.786
Net Change In Cash -155.913-82.9191.678-127.563130.65559.05123.23757.761-138.752193.253-48.840.5874.105-57.34-21.088-210.164304.037-15.9085.898-54.27958.2166.44
Cash At End Of Period 282.009437.922520.822329.144456.707326.052267.002143.76586.004224.75631.50380.34379.75675.651132.991154.079364.24360.20676.11415.05269.3317.554